Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Petauri is a purpose-built pharmaceutical services and commercialization consulting platform founded in 2023 by Dan Renick in partnership with Oak Hill Capital. The company specializes in helping life sciences organizations optimize market access and accelerate patient access to innovative treatments. It operates through several business units that provide integrated solutions spanning global pricing strategy, health economics and outcomes research (HEOR), medical affairs support, patient engagement programs, data analytics, and more. Since its founding it has launched/acquired several agencies including The Kinetix Group, FORCE Communications agencies, Mtech Access, Delta Hat, Brightly Network agencies, and Formulary Insights—all now operating under the "Powered by Petauri" brand umbrella. The firm’s mission centers on ensuring scientific breakthroughs reach patients with unmet needs by overcoming commercialization barriers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Petauri.